Back
Voyager Therapeutics Vs. Design Therapeutics Industry Stock Comparison
Sell
19
VYGR
Voyager Therapeutics
Last Price:
5.85
Seasonality Move:
-11.19%
Sell
35
DSGN
Design Therapeutics
Last Price:
5.35
Seasonality Move:
-1.96%
Sell
19
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy, Sell or Hold?
- The current Voyager Therapeutics [VYGR] share price is $5.85. The Score for VYGR is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- VYGR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy, Sell or Hold?
- The current Design Therapeutics [DSGN] share price is $5.33. The Score for DSGN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- DSGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VYGR Stock Price Chart
What is Voyager Therapeutics's stock price today?
-
The Voyager Therapeutics share price today is $5.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing selling pressure, which indicates risk of future bearish movement.
DSGN Stock Price Chart
What is Design Therapeutics's stock price today?
-
The Design Therapeutics share price today is $5.33
The current trend is moderately bullish and DSGN is experiencing selling pressure, which indicates risk of future bearish movement.
VYGR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 32.26 | Sell |
Chaikin Money Flow: | -254739 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.02 - 6.54) | Sell |
Bollinger Bands (100): | (6.64 - 8.72) | Sell |
DSGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 52.04 | Buy |
Chaikin Money Flow: | -110030 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.83 - 5.65) | Buy |
Bollinger Bands (100): | (3.75 - 5.13) | Buy |
VYGR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.06 | Sell |
20-day SMA: | 6.18 | Sell |
50-day SMA: | 7.04 | Sell |
200-day SMA: | 8.04 | Sell |
8-day EMA: | 6 | Sell |
20-day EMA: | 6.23 | Sell |
50-day EMA: | 6.81 | Sell |
200-day EMA: | 7.76 | Sell |
DSGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.53 | Sell |
20-day SMA: | 5.32 | Buy |
50-day SMA: | 4.92 | Buy |
200-day SMA: | 3.69 | Buy |
8-day EMA: | 5.45 | Sell |
20-day EMA: | 5.33 | Buy |
50-day EMA: | 4.94 | Buy |
200-day EMA: | 4.29 | Buy |
Voyager Therapeutics Earnings Growth & VYGR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, an increase next quarter of $0.07 per share, a decrease this year of $2.90 per share, and a decrease next year of $0.20 per share.
Design Therapeutics Earnings Growth & DSGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
Voyager Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Design Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |